Comparing the current results to its competitors, Resmed Inc reported Revenue increase in the 4 quarter 2026 by 9.22 % year on year, while most of its competitors have experienced contraction in revenues by -4.76 %, achieved in the same quarter.
Resmed Inc Net Income in the 4 quarter 2026 grew year on year by 0.98%, while most of its competitors have experienced a contraction in net income by -40.11 %.
With revenue growth of 9.22 % within Overall company, Resmed Inc achieved improvement in market share, within Overall company to approximately 17.93 %. << More on RMD Market Share.
*Market share is calculated based on total revenue.
September 3, 2025
In a pioneering move to elevate sleep health on a global stage, Resmed Inc has announced the launch of its cutting-edge Sleep Institute during the prestigious World Sleep Congress 2025. This innovative venture, officially known as the Global Clinical Insights Initiative, aims to foster advancements in sleep health care. As the company asserts its leadership role in the industry, it has also outshined its competitors in financial performance amidst a turbulent economic environment. Launching the Sleep Institute: A Step Towards Better Sleep HealthResmed’s introduction of the Sleep Institute is a landmark development in the world of sleep medicine. Unveiled at the World Sleep Congress 2025, the institute aims...
May 23, 2024
Groundbreaking Insights in Positive Airway Pressure Therapy: New Findings from ResMed-Supported Research at ATS 2024 In an era where respiratory conditions are increasing in prevalence and complexity, Positive Airway Pressure (PAP) therapy continues to play a pivotal role in managing conditions such as obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD). At the 2024 American Thoracic Society (ATS) meeting, a series of new studies funded by ResMed a global leader in digital health and cloud-connected medical devices have provided robust evidence that underscores the critical role of PAP therapy in the treatment of these respiratory disorders. Summary of Key Findings The research...
Inogen Inc is a medical device company that specializes in developing and manufacturing portable oxygen concentrators. Their business model involves designing and selling innovative oxygen therapy solutions directly to patients, healthcare providers, and home medical equipment providers. By eliminating the need for third-party distributors, Inogen Inc aims to provide cost-effective and accessible products that improve the quality of life for individuals relying on supplemental oxygen therapy.
Masimo Corp is a medical technology company that focuses on developing and manufacturing innovative monitoring devices for patient care. Their business model revolves around creating and selling advanced noninvasive monitoring solutions to healthcare providers worldwide. They also generate revenue through licensing agreements, providing maintenance and support services, and selling disposable products and accessories related to their monitoring devices.
Non Invasive Monitoring Systems Inc Share Performance
+374,566.67%
One Year
Non Invasive Monitoring Systems Inc
Profile
Non Invasive Monitoring Systems Inc operates by providing non-invasive medical monitoring solutions that utilize advanced technologies to measure various physiological parameters for improved patient care in healthcare settings. Their business model focuses on developing and selling innovative monitoring devices and systems to healthcare professionals and institutions.
Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv's business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.
Sources:
Resmed Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Resmed Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
